-
GEN – Genetic Engineering & Biotechnology News3 months ago
Bioengineered Implants Deliver Multi-Drug Therapy in Animal Models
In a new paper, scientists from Northwestern University and their collaborators at Rice University and Carnegie Mellon University report on their progress towards developing so-called implantable...
-
GEN – Genetic Engineering & Biotechnology News3 months agoGut-Immune Link Identified in Multiple Sclerosis-Related Neuroinflammation
Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS)....
-
STAT News – Biotech3 months agoSTAT+: Amid focus on food, FDA leader briefs lawmakers on priorities
WASHINGTON — Food and Drug Administration officials briefed senators on the agency’s plans for food policy for 2026, according to a person familiar with the meeting....
-
Endpoints News3 months ago
Otsuka buys Transcend Therapeutics for $700M upfront
Otsuka is buying neuropsychiatric drugmaker Transcend Therapeutics in a deal worth roughly $1.2 billion, further bolstering a class of drugs that are supposed to provide the...
-
Endpoints News3 months ago
CHMP recommends subcutaneous form of Sanofi’s Sarclisa and four new drugs
The European Medicines Agency’s human medicines committee has recommended the approval of four new drugs and a new form of Sanofi’s multiple myeloma drug. CHMP gives...
-
STAT News – Biotech3 months agoSTAT+: In private meetings, White House works to win pharma companies’ support for drug pricing bill
WASHINGTON — The White House has drafted legislative text for its drug pricing policy, and officials are in the process of sharing it with more than...
-
Uncategorized3 months agoOtsuka picks up PTSD drug with $700M Transcend buy
The buyout, which includes another $525 million in floated payouts, hands Otsuka a medicine it sees as a possibly “paradigm-shifting therapy” in psychiatry.
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers
This week, agentic AI steps into the limelight buoyed by the momentum from generative AI. And there’s a new virtual cell model in town courtesy of AI-drug developer Xaira Therapeutics. From...
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Lonza Media Development Lab Set Up in Singapore
Lonza launched a media development lab at its Singapore site to support bioprocessing clients in optimizing their media formulations and facilitating a transition to GMP manufacturing....
-
BioPharma Dive – AI / Data3 months agoAstraZeneca lung drug gets ‘surprise’ win in COPD trials
The treatment, tozorakimab, succeeded where other similar therapies failed and could help a broader group of COPD patients than Dupixent.
Amgen shores up Tavneos’ FDA defense with Duke data analysis
